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ABSTRACT. The transgenic potato ‘SpuntaG2’ (Solanum tuberosum), which is resistant to potato tuber moth
(Phthorimaea operculella), was subjected to protein safety evaluations including protein equivalency tests for the
Cry1Ia1 protein from ‘SpuntaG2’ and bacterially produced Cry1Ia1, toxicity and allergenicity evaluations of
Cry1Ia1 protein, and compositional equivalency of ‘SpuntaG2’ compared with non-transgenic ‘Spunta’. Western blot
analysis and biological activity assays showed molecular and functional equivalency between ‘SpuntaG2’-derived
Cry1Ia1 protein and bacteria-derived Cry1Ia1 protein. Comparison of the Cry1Ia1 amino acid sequence to known
amino acid sequences revealed no significant homology to known toxins or known allergens. Acute toxicity studies
using rodents were used to calculate an acceptable daily intake (ADI) value of 20 mgkg–1 body weight per day. The
ADI value was then used to calculate a margin of exposure (MOE) of 2,222,222, which is more than 22,000 times
greater than the commonly used target MOE of 100. Digestibility and thermostability assays determined that Cry1Ia1
was fully digested within 30 s of exposure to pepsin and inactive after 3 to 4 minutes at 100 8C, indicating that it would
not be a potential allergen. Compositional analyses revealed no difference between ‘SpuntaG2’ and non-transgenic
‘Spunta’. These results strongly indicate that the Cry1Ia protein and the transgenic potato ‘SpuntaG2’ is not a human
health risk.

‘SpuntaG2’, a transgenic potato resistant to potato tuber
moth, has been previously described by Douches et al. (2002).
‘SpuntaG2’ contains two foreign genes: cry1Ia1, a gene derived
from the soil-borne bacterium Bacillus thuringiensis and nptII,
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a gene derived from the bacterium Escherichia coli (Beck et al.,
1982). Cry1Ia1 is a protein that is toxic to potato tuber moth,
and acts by binding to specific receptors on the membranes
of epithelial cells in the target insect’s midgut. Binding to the
receptors causes an ion channel to form between the cell
cytoplasm and the external environment, resulting in the loss
of osmotic regulation and insect death (Gill et al., 1992).
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Another foreign gene that is expressed in ‘SpuntaG2’ is nptII
(neomycin phosphotransferase), which is a protein that confers
resistance to the antibiotic kanamycin and is used as a selectable
marker during the transformation process. The 29-kDa neomycin phosphotransferase enzyme inactivates aminoglycoside
antibiotics by transferring the g-phosphate from ATP to the respective antibiotic. A complete characterization of the ‘SpuntaG2’
transgenic event has been conducted (Zarka et al., 2010) and
they showed that there is a single copy of each gene with no
interruption of endogenous genes during the transformation
process. That article is the first one in a three-article series and
contains a complete research rationale.
We report here, in the second article of the series, on the
protein safety evaluations conducted on the foreign proteins in
‘SpuntaG2’ plants. The Cry1Ia1 protein analysis includes protein
equivalency tests for the Cry1Ia1 protein from ‘SpuntaG2’ and
bacterially produced Cry1Ia1, toxicity and allergenicity evaluations of Cry1Ia1 protein, compositional equivalency of ‘SpuntaG2’ compared with non-transgenic ‘Spunta’, molecular and
functional equivalency between ‘SpuntaG2’-derived Cry1Ia1
protein and bacterial-derived Cry1Ia1 protein, and homology
analysis to known toxins or known allergens. These experiments
were conducted in accordance with the guidelines set forth by
Codex Alimentarius (2003), which represent the international
scientific standard on the process and data requirements for
assessment of food safety relating to genetically modified plants.
Particular attention was given to the requirements pertaining to
food and feed safety, as contained in sections 5.1 and 5.2 of the
guidelines for the use of genetically modified organisms. The
other foreign protein in ‘SpuntaG2’ is the NPTII protein and has
been previously evaluated and proven safe by the European Food
Safety Authority (2007) and Fuchs et al. (1993b). The amount of
NPTII expression in ‘SpuntaG2’ was evaluated and compared
with other reported levels of expression.
Materials and Methods
PRODUCTION OF PURIFIED CRY1IA1 PROTEIN. The expression
vector system pET28b (Novagen, Madison, WI) was used for
cloning and expression of the cry1Ia1 gene. pET28b was
digested with the BamHI restriction enzyme and the linearized
plasmid was then ligated to a BamHI fragment of the cry1Ia1
gene. The resulting plasmid was sequenced and named
pSPUD56. It was then transformed into the E. coli strain
BL21(DE3) (Novagen), a general-purpose expression host.
The protein was expressed with an N-terminal histidine tag,
which enabled it to be purified with Ni-NTA agarose (Qiagen,
Valencia, CA).
Ten liters of E. coli BL21(DE3) pSPUD56 were produced
at the Protein Expression Laboratory of Michigan State University (East Lansing) according to the following protocol: a
250-mL overnight culture of BL21(DE3) pSPUD56 was used
to inoculate a 10-L vessel containing HM medium. The HM
medium was prepared by dissolving 9 g of KH2PO4, 6 g of
K2HPO4, 4 g of Na2HPO4, and 3 g of (NH4)2HPO4 in 940 mL of
distilled H2O and autoclaving this for 30 min at 121 C on
liquid cycle. After cooling the solution to <40 C, 40 mL of
autoclaved 50% glucose, 15 mL of autoclaved 1 M MgSO4,
and 5 mL of sterile trace element solution were added. The trace
element solution consisted of 10 g of FeSO4, 2.5 g of
ZnSO47H2O, 1 g of CuSO45H2O, 1 g of MnSO45H2O, 1 g
of CoCl126H2O, 1 g of Na2MoO42H2O, 5 g of CaCl122H2O,
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and 0.2 g of Na2B4O710H2O dissolved in 1 L of 5M HCl. The
10-L vessel containing the HM medium and BL21(DE3)pSPUD56 culture was agitated at 500 rpm with an air flow rate of
1 Lmin–1 while the pH was controlled by adding ammonia.
After 12 h of culture, IPTG was added to a final concentration
of 0.5 mM to induce production of the Cry1Ia1 protein. The
dissolved oxygen was maintained below 10% (w/v) by adding
2.8 M glucose as needed. After 6 h of induction, the cells were
harvested by centrifugation and the wet pellet was stored at
–80 C until purification.
The E. coli pellet was taken from –80 C and resuspended
in PN buffer (50 mM NaH2PO4 and 0.3 M NaCl, pH 7.8)
containing 1% Triton X-100 (Bio-Rad, Hercules, CA) and 1
mgmL–1 lysozyme in a centrifuge tube. The cell suspension
was prepared for and purified with Ni-NTA agarose (Qiagen)
according to the manufacturer’s instructions. The protein was
eluted by adding PN buffer containing 0.5% Triton X-100 and
0.3 M imidazole. The eluate (containing the purified protein)
was collected. The protein solution was then concentrated and
simultaneously changed to PEN buffer [50 mM NaH2PO4,
0.3 M NaCl, 0.5 mM EDTA, pH 7.8, Protease Inhibitor (Roche
Applied Science, Indianapolis), and 10% glycerol], using
centrifugational filter devices (Amicon Ultra-15; Millipore,
Bedford, MA). The concentration of protein samples was determined by using a commercially available Bradford Reagent
(Bio-Rad) according to manufacturer’s instructions. Purified
protein preparations were stored at –80 C.
The purified protein preparation from the previous step was
thawed and concentrated further to 160 mgmL–1. A sample was
diluted and separated by electrophoresis on a 10% Tris Glycine
SDS-PAGE (Bio-Rad) according to Laemmli (1970). After
electrophoresis, the gel was stained with SimplyBlueä SafeStain (Invitrogen, Carlsbad, CA) according to the manufacturer’s instructions to confirm the size and purity of the sample.
Based on the intensity of the Cry1Ia1 band, the preparation was
judged to be >90% pure.
EQUIVALENCY OF IN VITRO CRY1IA1 PROTEIN FROM E. COLI
AND C RY1IA1 PROTEIN FROM ‘SPUNTAG2’. Non-transgenic
‘Spunta’ and ‘SpuntaG2’ proteins were compared by western
blot analysis with E. coli-derived Cry1Ia1 protein previously
described by Li et al. (1999). The biological activities of
Cry1Ia1 protein purified from E. coli and Cry1Ia1 protein
contained in sap from ‘SpuntaG2’ were also compared. While
the target insect for ‘SpuntaG2’ is the potato tuber moth, there
currently is no known artificial diet capable of maintaining this
insect during the larval stages. However, Cry1Ia1 is also toxic
to the tobacco hornworm (Manduca sexta), an insect for which
eggs and an artificial diet have been developed and are commercially available. Therefore, the tobacco hornworm was used
for this study. The eggs were purchased from the North Carolina
State University Entomology Insectary (Raleigh). Once the first
instar larvae emerged, the insects were placed in 24-well plates
(Cellbind; Corning, Corning, NY) containing 1 mL/well commercially prepared tobacco hornworm diet (Carolina Biological
Supply, Burlington, NC) and one newly hatched hornworm per
well. Purified E. coli Cry1Ia1 was mixed into the wells at
concentrations of 0.1, 0.5, 1.0, 1.5, and 2.5 mgmL–1. As a control,
100 mL of ddH2O was mixed with the diet (0 mg of Cry1Ia1
protein). Twenty-four replicate wells were prepared for each
protein concentration. The larvae were added and the plates were
placed at room temperature for 72 h. The surviving larvae were
recorded.
J. AMER. SOC. HORT. SCI. 135(4):325–332. 2010.

To determine the activity of the Cry1Ia1 protein in ‘SpuntaG2’,
leaf tissue was extracted from the non-transgenic ‘Spunta’
control or from ‘SpuntaG2’. Using a mortar and pestle, leaf tissue
samples were ground and the sap was removed by pipetting. This
sap sample was centrifuged at 2000 gn for 5 s to pellet any large
debris. The sap was transferred to a new tube. The sap was
weighed and it was determined that the sap represented 0.001 g
of fresh wet leaf tissue weight per microliter. The liquid sap was
then mixed into the commercial diet in the wells (10 mL = 0.01 g
tissue, 25 mL = 0.025 g tissue, 50 mL= 0.05 g tissue, and 100 mL =
0.1 g tissue). The larvae were added and the plates were placed
at room temperature for 72 h. The surviving larvae were then
recorded.
TOXICOLOGY. Homology of Cry1Ia1 protein to known toxins
was assessed using the approach described by Rice et al. (2008).
The amino acid sequence of the Cry1Ia1 protein was used to
query the database using the algorithm, Basic Local Alignment
Search Tool Protein (BLASTP) (Altschul et al., 1997). The
BLASTP algorithm was implemented via the National Center
for Biotechnology Information (NCBI, 2010). The default
parameters were used. This implementation of the BLASTP
algorithm searches the protein-nr public database of protein
sequences. The delimiting phrase ‘‘toxin OR toxic NOT insecticidal NOT pesticidal NOT delta endotoxin’’ was used. This
delimiter was used because an initial search using just the phrase
‘‘toxin OR toxic’’ returned only Cry proteins, and was therefore
not informative.
The acute toxicity of Cry1Ia1 protein was evaluated by MPI
Research, Mattawan, MI (MPI Research, Inc., 2008). Purified
Cry1Ia1 protein was used and the study was conducted in
compliance with the U.S. Food and Drug Administration
(USFDA, 2008). USFDA and international guidelines were
followed (International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for
Human Use, 1997; USFDA, 2004). One treatment group of 10
male and 10 female Crl:CD1Ò (Icr) mice was administered the
test article, Cry1IA1 protein, at a dose level of 2000 mgkg–1
and at a dose volume of 12.5 mLkg–1. One additional group
of 20 animals (10 males and 10 females) served as the control
and received the vehicle, control buffer, at a dose volume of
12.5 mLkg–1. The test article or vehicle was administered via
oral gavage, once on Day 1. Observations for mortality,
morbidity, injury, and the availability of food and water were
conducted twice daily for all animals. Clinical observations
were conducted once on day 1 (1 h post dose), day 7, and day
14. Body weights and food consumption were measured and
recorded weekly. At study termination, necropsy examinations
were performed, organ weights were recorded, and selected
tissues were preserved.
ALLERGENICITY. The search for sequence similarity between
the Cry1Ia1 protein and known allergens was conducted by
comparing the amino acid sequence of Cry1Ia1 with the
database of known allergens, AllergenOnline (University of
Nebraska-Lincoln, 2010). Sequence similarity was done using
the FASTA3 algorithm (Pearson, 2000), accessed through the
AllergenOnline website. The website conducts two types of
sequence searches: 1) an overall FASTA search of the AllergenOnline database, and 2) an 80-amino acid sliding window
search in which sequential 80-amino acid segments of the
protein are generated and each is used to query the AllergenOnline database. In these sequence searches, Codex Alimentarius
(2003) considers allergenicity to be a possibility if there is 35%
J. AMER. SOC. HORT. SCI. 135(4):325–332. 2010.

(or more) identity between the protein in question and a known
allergen in a segment of at least 80 amino acids.
In addition to sequence analyses, Codex Alimentarius (2003)
also recommends a test to determine the ability of pepsin to
digest the protein in question. Therefore, the digestibility of the
Cry1Ia1 protein was investigated in an in vitro digestibility assay
according to the procedure followed by Fu et al. (2002). To
initiate a time course experiment, 665 mL of SGF solution was
incubated at 37 C for 2 min, and then 35 mL of the purified
Cry1Ia1 protein at 5 mgmL–1 was added; 100 mL of sample was
removed and added to a separate tube containing 35 mL of 200
mM NaHCO3 (pH 11.0) and 50 mL 3· Laemmli sample buffer.
The neutralized samples were analyzed by SDS polyacrylamide
resolving gel run according to Laemmli (1970) along with a
0 time point, which consisted of 0.7 mg of Cry1Ia1 protein that
was added to already neutralized SGF. Results were visualized
by staining the gel with Coomassie Blue.
Another criterion for assessing the allergenic potential of
a protein is its thermostability as measured by activity (Delaney
et al., 2008). The stability of the Cry1Ia1 protein after being
exposed to heat was studied using tobacco hornworm as
a test insect due to the availability of an artificial diet capable
of maintaining this insect during the larval stages. The tobacco hornworm eggs were purchased from the North
Carolina State University Entomology Insectary (Raleigh).
Cellbind 24-well plates were used for this study with two
wells per dose of Cry1Ia1 per time point, and only one well
per time point, up to 3 min, was used for the control. Purified
Cry1Ia1 protein was placed in a hot block set at 100 C. At 0,
1, 2, 3, 4, and 5 min a sample (10 or 100 mgmL–1 in 100 mL of
ddH2O) was removed and mixed into the diet (Carolina
Biological Supply). As a control, 100 mL ddH2O was mixed
with the diet (0 mg of Cry1Ia1 protein). Two newly hatched
first instar larvae were added to each well and the plates were
placed at room temperature for 72 h. The surviving larvae
were then recorded.
COMPOSITIONAL ANALYSIS OF ‘SPUNTAG2’. The nutritional
composition of ‘SpuntaG2’ was analyzed in comparison with
non-transgenic ‘Spunta’. This analysis, in conjunction with
a comparison of agronomic characteristics, are the primary
analyses recommended by Codex Alimentarius (2003) for the
assessment of unintended effects resulting from the transformation process. The components analyzed were based on
those specified by the Organization for Economic Co-operation
and Development (OECD, 2002; Rogan et al., 2000). Potatoes
were sampled in South Africa from four replicate plots of
‘SpuntaG2’ and ‘Spunta’ at two locations (Kokstad and Petrus
Steyn) and from three replicate plots at Roodeplaat. Freshly
harvested tubers from each plot were placed in individual piles.
‘Spunta’ and ‘SpuntaG2’ tubers (3 kg) were randomly
removed from each pile and placed in bags. About 1 kg of
fresh tubers was removed from the bags and the tubers were
washed and diced into cubes about 1 cm3 in size. The diced
tuber pieces were placed in plastic bags, frozen at –20 C, and
sent to and analyzed by Agricultural Research Council-Irene
Analytical Services (Pretoria, South Africa), a South African
National Accreditation System accredited laboratory. The data
were analyzed by two-way analysis of variance, with Buonferroni post-tests, using GraphPad PRISM software (version 5.0
for Mac; GraphPad PRISM Software, San Diego). Nutrients
that were not detected were not included in the statistical
analysis.
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A rodent feeding study entitled, ‘‘Testing the nutritional dry weight. This dilution was determined in previous experiadequacy of a genetically modified ‘Spunta’ potato using the rat ments to provide readings in the linear range of response for the
model,’’ was conducted by the Agricultural Research Council assay. Samples were loaded onto pre-coated ELISA plates (100
Toxicology (Pretoria, South Africa) as an additional assurance mL/well) along with standards comprised of 2-fold serial
of nutritional adequacy and absence of unintended effects. dilutions of positive controls, as well as negative control
Before the study described in this article, a pilot study was samples on each plate. The optical density of each well was
conducted to determine the nutritional adequacy of various test read with a microplate reader (model 50; Varian Cary, Palo
doses of nontransgenic potato on rats. This study showed no Alto, CA). Four replicate experiments, done on different dates,
adverse nutritional effect of 30% (w/v) potato, the highest dose were conducted. Concentrations of NPTII protein were based
tested, and therefore this dose was chosen for the main study. upon standards run on the same plate, at the same time.
Pellets containing 30% (w/v) potato meal were made by mixing
the freeze-dried ‘Spunta’ or ‘SpuntaG2’ potato tubers with the
Results
milled standard rodent pellets (Onderstepoort Biological ProdWestern blot results (Fig. 1) show that the rabbit polyclonal
ucts, Pretoria, South Africa) and reformulating pellets from the
mixture. Standard proximate analysis of the freeze-dried tubers as Cry1Ia1 antibody used in this experiment reacts with the
well as test and control pellets was done to assure nutritional Cry1Ia1 and is equal in size to the Cry1Ia1 protein purified
from E. coli. The antibody reacts non-specifically with three
equivalence.
Young Sprague-Dawley rats (female n = 30, male n = 30), proteins found in the ‘SpuntaG2’ extracts; however, it also
with masses between 49 and 78 g, were obtained from National reacts in the non-transformed extracts.
M. sexta larvae were sensitive to purified Cry1Ia1 protein
Health Laboratory Services (Johannesburg, South Africa) and
kept in an environmentally controlled small animal facility. with a dose of 2.5 mgmL–1 producing 100% mortality (Table 1).
During the adaptation period of 1 week, tap water and standard ‘SpuntaG2’ leaf extracts showed a similar effect on M. sexta
rat pellets were provided ad libitum. The rats were divided larvae with even the lowest dose tested resulting in 50%
randomly into six groups (n = 10) according to the following mortality. In contrast, the number of surviving insects in the
scheme: control female and male groups: standard pellets only; ‘Spunta’ non-transgenic control extract of 0.1 g/well was equal
‘Spunta’ female and male groups: pellets containing 30% (w/v) to the number of surviving insects in the 0 mgmL–1 Cry1Ia1
‘Spunta’; ‘SpuntaG2’ female and male groups: pellets contain- control (Table 1).
To assess whether the Cry1Ia1 protein has homology to any
ing 30% (w/v) ‘SpuntaG2’.
During the main trial (90 d) rats were kept in single cages known toxin, the amino acid sequence of the Cry1Ia1 protein
facing one another and tap water and feed were provided ad was used to query the database using the algorithm, BLASTP
libitum. The individual body masses as well as the feed intake (Altschul et al., 1997). Although we attempted to remove Cry
were recorded twice weekly to compute and compare some of proteins from the search results to focus on proteins that had
the performance parameters (body mass gain, food intake, final known human or animal toxicity, most of the results of this
body mass, and feed efficiency). Temperature was maintained search were still Cry insecticidal proteins. Those that were not
at 23 C to 24 C, relative humidity varied between 43% and Cry proteins had very low similarity to Cry1Ia1 (E score > 2),
65%, and lighting was controlled on a 12/12-h light/dark cycle and are therefore unlikely to be related in function to Cry1Ia1.
(lights on at 0600 HR; lights off at 1800 HR). The experiment Furthermore, for proteins to share the same function, a sequence
was ended by euthanizing the rats
(overdose of pentobarbitone sodium
200 mgmL –1 at a dose of 1–2
mLkg–1 intraperitoneally), immediately followed by collecting blood
from the heart (1.5 mL with a 24 G
needle) and removing the liver,
heart, kidney, spleen, lungs, and
1. Equivalence of apparent molecular weight and antigenic re-activities of Escherichia coli Cry1Ia1 and plant
ovaries or testes for weighing. The Fig.
extract from transgenic potato lines expressing the protein Cry1Ia1 (Li et al., 1999). Lane 1 = non-transgenic
blood was centrifuged (at 1200 gn
potato ‘Spunta’; lane 2 = non-transgenic potato ‘80–1’; lanes 3–11 = transgenic Cry1Ia1 ‘Spunta’ lines 6a1, 6a2,
for 10 min) and the serum was
6a3, 6a4, and 6a5,‘SpuntaG2, ‘SpuntaG3,’ 80–1.9, and 80–1.25, respectively; lane 12 = blank; lane 13 = E. coli
Cry1Ia1 protein.
collected and submitted for clinical
chemistry and hematology on whole
blood.
Table 1. Toxicity of purified Escherichia coli Cry1Ia1 protein and potato leaf extracts from ‘Spunta’
DETERMINATION OF NPTII
and ‘SpuntaG2’ on Meduca sexta larvae.
EXPRESSION IN ‘SPUNTAG2’. A com‘Spunta’ and ‘SpuntaG2’
Larvae living
Larvae living
mercial NPTII ELISA kit (catalog Cry1Ia1–1
(g of leaf extract)
after 72 h (no.)z
after 72 h (no.)z
no. PSP 73000; Agdia, Elkhart, IN) (mgmL = mg/well)
19
‘Spunta’ 0.10
19
was used to determine the level of 0.0
0.1
7
‘Spunta’
0.01
20
NPTII protein present in ‘Spun0.5
5
‘SpuntaG2’
0.10
2
taG2’. Freeze-dried leaves were
2
‘SpuntaG2’ 0.05
0
ground in sample buffer (PEB1, 1.0
3
‘SpuntaG2’ 0.025
6
supplied by the manufacturer) at 1.5
0
‘SpuntaG2’ 0.01
10
a concentration of 10 mgmL–1 and 2.5
–1
z
Twenty-four first instar larvae were tested per protein concentration.
were then diluted to 2.5 mgmL
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identity of at least 40% is required (Wilson et al., 2000). None
of the non-Cry1 proteins shared that level of sequence identity,
and the matches returned by BLASTP were for only portions of
the proteins in the database.
The acute toxicity test established a no adverse effect level
(NOAEL) of 2000 mgkg–1 body weight per day, from which an
ADI of 20 mgkg–1 body weight per day was calculated
(Benford, 2000). Using the expression levels of Cry1Ia1 in
‘SpuntaG2’ tubers [0.12 mgg–1 fresh weight (Zarka et al.,
2010)], the expected dose of Cry1Ia1 consumed by the South
African population can be estimated. The South African
Medical Research Council (2002) estimates average adult
consumption of potatoes at 7.9 gkg–1 body weight per day.
Therefore, the estimated daily intake (EDI) of Cry1Ia1 protein,
assuming 100% of the potatoes consumed in South Africa
would be ‘SpuntaG2’, is 0.00000012 g Cry1Ia1 protein per
gram of fresh tuber weight · 7.9 = 0.0000009 gkg–1 body
weight (i.e., 0.0009 mgkg–1) per day. This dose is 22,000 times
less than the ADI (20 mgkg–1 body weight per day). In other
terms, the margin of exposure is 2000/0.0009 = 2,222,222,
which is more than 22,000 times greater than the commonly
used target MOE of 100.
The sequence comparison of the Cry1Ia1 protein to known
allergens revealed that no sequence similarity exists between
Cry1Ia1 and known allergens. In digestibility assays, Cry1Ia1
protein digested within 30 s in simulated gastric fluid (Fig. 2).
The controls with Cry1Ia1 alone (lanes 9 and 10) demonstrate
that the protein is specifically degraded by pepsin. The speed of
digestion is consistent with other non-allergenic proteins and in
particular other Cry proteins that have obtained regulatory
approval in several countries worldwide.
One other criterion for assessing the allergenic potential of
a protein is its thermostability as measured by activity (Delaney
et al., 2008). Therefore, the stability of the Cry1Ia1 protein after
being exposed to heat was studied using tobacco hornworm
larvae. The number of surviving hornworm larvae in each test
well is shown in Table 2. Survival of tobacco hornworms fed
Cry1Ia1 was at 50% of the controls by 2 min, and at the same
level as the controls at 3 min. These results indicate that the
Cry1Ia1 protein is inactivated by heating to 100 C for 3 to 4 min.
The nutritional composition of ‘SpuntaG2’ was analyzed in
comparison with non-transgenic ‘Spunta’. This analysis is one
of the primary analyses recommended by Codex Alimentarius
(2003) for the assessment of unintended effects resulting from
the transformation process. The components analyzed were
based on those specified by the OECD (2002) and by Rogan
et al. (2000). None of the levels of the nutritional and quality
parameters and vitamin, mineral, and amino acid composition
of ‘SpuntaG2’ and ‘Spunta’ potato tubers differed to a statistically significant degree, with the exception of lysine at only one
location, Kokstad (Table 3). Lysine levels of ‘SpuntaG2’ and
‘Spunta’ were not significantly different at either of the other
two testing locations. The lysine level of ‘SpuntaG2’ was lower
than ‘Spunta’ at Kokstad, and was slightly lower than the
reported range of lysine (77–171 mg/100 g) in Rogan et al.
(2000). However, the lysine levels were not significantly
different at the other two locations, and all were on the lower
end of the reported range. Based on these analyses, we did not
reject the null hypothesis that nutrient levels were the same for
‘SpuntaG2’ and ‘Spunta’ at all three locations.
In a rodent feeding study, six groups of rats were evaluated
where male and female groups were fed on standard pellets,
J. AMER. SOC. HORT. SCI. 135(4):325–332. 2010.

Fig. 2. Polyacrylamide protein electrophoresis time course of digestion of
Cry1Ia1 protein in simulated gastric fluid (SGF). STD = molecular weight
marker; lane 1 = SGF + pepsin only, 60 min; lanes 2–9 = SGF + pepsin and
Cry1Ia1 for the indicated time (min); lane 10 = SGF + Cry1Ia1 only, 60 min;
lane 11 = SFG + Cry1Ia1 only, 0 min.

Table 2. Bioactivity test on heat treated Escherichia coli-produced
Cry1Ia1 protein using Meduca sexta larvae as the test subject.
Time at 100 C (min)
0
1
2
3
4
5
Cry1Ia1
(mgmL–1) Replication
Living hornworms after 72 h (no.)z
10
1
0
0
1
1
1
2
10
2
0
0
1
2
2
2
100
1
0
0
1
2
2
1
100
2
0
0
1
2
2
2
0
1
2
2
1
2
z

Each well contained 1mL of diet, the designated amount of Cry1Ia1
protein, and two newly hatched M. sexta larvae.

pellets containing ‘Spunta’, and pellets containing ‘SpuntaG2’.
The control and experimental groups had no significant
differences for the parameters tested, which included body
weight, organ weight, food consumption, clinical sign changes,
clinical pathological alterations, clinical chemistry, and hematology (Agricultural Research Council, unpublished results).
Therefore, the test animals responded in the same way to the
‘SpuntaG2’ potato as to its conventional counterpart (‘Spunta’),
following consumption.
Based on the results of ELISA tests, the concentration of
NPTII protein in leaf tissue was 11.34 mgg–1 fresh weight.
NPTII protein accounts for 0.07% of total protein, given that
1.6% of leaf fresh weight is protein (Stone and Lavrik, 1994).
This is consistent with results of studies that have measured
nptII gene expression in other transgenic potato lines at 2.64 mg
of NPTII protein per gram fresh weight, or 0.02% of total
protein (Stone and Lavrik, 1994).
Discussion
In a previous study, ‘SpuntaG2’, a potato cultivar containing
the cry1Ia1 gene, was extensively characterized at the molecular level (Zarka et al., 2010). The results indicated that the
cry1la1 gene in ‘SpuntaG2’ was unchanged during the transformation process, was stably integrated into the potato
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Table 3. Mean comparison of nutritional and quality parameters and vitamin, mineral, and amino acid composition of ‘SpuntaG2’ and ‘Spunta’
potato tubers grown at three South African locations (Kokstad, Petrus Steyn, and Roodeplaat). The least-squares means of ‘SpuntaG2’ and
‘Spunta’ were compared within each location.
Field location
Kokstadz
Petrus Steyny
Roodeplaat
SpuntaG2
Spunta
SpuntaG2
Spunta
SpuntaG2
Spunta
Component
Unit
SE
Mean
SE
Mean
SE
Mean
SE
Mean
SE
Mean
SE
Mean
Dry matter
%
15.6
0.34
15.8
0.34
15.1
0.34
15.7
0.34
15.2
0.39
14.6
0.39
Moisture
%
84.4
0.34
84.2
0.34
84.9
0.34
84.3
0.34
84.8
0.39
85.4
0.39
Ash
%
0.878 0.028
0.845 0.028
0.845 0.028
0.760 0.028
0.887 0.032
0.843 0.032
Protein
%
2.08
0.05
2.12
0.05
2.29
0.05
2.26
0.05
1.82
0.06
1.63
0.06
Fat (ether extraction) %
0.078 0.019
0.100 0.019
0.068 0.019
0.105 0.019
0.113 0.022
0.087 0.022
Fiber (crude)
%
0.385 0.024
0.325 0.024
0.378 0.024
0.340 0.024
0.543 0.027
0.457 0.027
Arginine
g/100 g
0.100 0.003
0.093 0.003
0.108 0.003
0.093 0.003
0.087 0.004
0.070 0.004
Serine
g/100 g
0.053 0.003
0.053 0.003
0.048 0.003
0.055 0.003
0.040 0.003
0.040 0.003
Aspartic acid
g/100 g
0.288 0.022
0.270 0.022
0.273 0.022
0.310 0.022
0.260 0.026
0.207 0.026
Glutamic acid
g/100 g
0.318 0.016
0.305 0.016
0.328 0.016
0.358 0.016
0.267 0.018
0.207 0.018
Glycine
g/100 g
0.040 0.000
0.040 0.000
0.040 0.000
0.040 0.000
0.040 0.000
0.030 0.000
Threonine
g/100 g
0.058 0.003
0.058 0.003
0.048 0.003
0.055 0.003
0.050 0.004
0.037 0.004
Alanine
g/100 g
0.080 0.003
0.088 0.003
0.090 0.003
0.100 0.003
0.083 0.003
0.073 0.003
Tyrosine
g/100 g
0.058 0.006
0.053 0.006
0.053 0.006
0.055 0.006
0.057 0.007
0.047 0.007
Proline
g/100 g
0.043 0.002
0.043 0.002
0.040 0.002
0.045 0.002
0.040 0.003
0.037 0.003
Methionine
g/100 g
0.020 0.002
0.020 0.002
0.025 0.002
0.023 0.002
0.020 0.002
0.010 0.002
Valine
g/100 g
0.078 0.002
0.078 0.002
0.075 0.002
0.080 0.002
0.070 0.002
0.070 0.002
Phenylalanine
g/100 g
0.065 0.003
0.065 0.003
0.063 0.003
0.065 0.003
0.057 0.003
0.050 0.003
Isoleucine
g/100 g
0.053 0.002
0.053 0.002
0.050 0.002
0.050 0.002
0.050 0.003
0.040 0.003
Leucine
g/100 g
0.073 0.003
0.075 0.003
0.068 0.003
0.075 0.003
0.067 0.003
0.060 0.003
Histidine
g/100 g
0.053 0.004
0.043 0.004
0.050 0.004
0.050 0.004
0.043 0.004
0.037 0.004
Lysine
g/100 g
0.043 0.009
0.095 0.009
0.058 0.009
0.095 0.009
0.083 0.010
0.083 0.010
Cysteine
g/100 g
0.018 0.002
0.020 0.002
0.018 0.002
0.015 0.002
0.010 0.003
0.013 0.003
Tryptophan
g/100 g
0.020 0.001
0.020 0.001
0.018 0.001
0.020 0.001
0.020 0.002
0.013 0.002
Vitamin C
mg/100 g
5.40
0.52
4.80
0.52
6.23
0.52
5.51
0.52
4.06
0.60
2.83
0.60
Carbohydrates
%
12.6
0.34
12.7
0.34
11.9
0.34
12.6
0.34
12.4
0.40
12.0
0.40
Energy
kJ/100 g 251.8
5.7
255.8
5.7
243.5
5.7
256.5
5.7
246.0
6.6
235.0
6.6
Sucrose
g/100 g
0.056 0.029
0.049 0.029
0.110 0.048 non-det
—
0.297 0.028
0.310 0.028
Glucose
g/100 g
0.313 0.025
0.340 0.025
0.220 0.025
0.258 0.025
0.087 0.029
0.193 0.029
Magnesium
mg/100 g 14.5
0.84
15.9
0.84
17.2
0.84
15.2
0.84
15.2
0.97
14.6
0.97
Potassium
mg/100 g 347.2
21.5
370.9
21.5
374.0
21.5
343.7
21.5
291.0
24.8
352.7
24.8
Copper
mgkg–1
1.88
0.13
1.34
0.13
1.47
0.13
1.18
0.13
1.68
0.15
1.34
0.15
z
Least-squares means for the two potato lines (presented with standard errors) in bold are significantly different compared individually within
each location at a = 0.05.
y
Sucrose levels were non-detectable for ‘Spunta’ at the Petrus Steyn location.

genome, did not interrupt or otherwise affect any functional
potato genes, and it did not introduce any new open reading
frames that would be of concern.
The research reported here was done to assess the safety of
expressed foreign proteins in ‘SpuntaG2’ (Cry1Ia1 and NPTII)
and is summarized in Table 4. Western blot analysis and larval
feeding studies demonstrated size and functional equivalency
between Cry1Ia1 protein from ‘SpuntaG2’ and E. coli-derived
Cry1Ia1. Furthermore, sequence analysis of the protein
revealed no significant match with known toxins except for
other Cry insecticidal proteins. Acute toxicity tests from our
study and ELISA data from Zarka et al. (2010) allowed us to
calculate an ADI for the Cry1Ia1 protein. Assuming a diet
including only ‘SpuntaG2’ potatoes, the EDI for the Cry1Ia1
protein was more than 22,000 times less than the ADI. This
highly conservative safety level is assurance that Cry1Ia1
protein will not have toxic effects on humans who consume
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the protein in ‘SpuntaG2’ and other cultivars into which the
cry1Ia1 gene will be backcrossed.
To assess the allergenicity of Cry1Ia1 protein, the first step
recommended by Codex Alimentarius (2003) is to consider the
source of the protein. Bacillus thuringiensis has been the source
of numerous genes expressing various Cry proteins. Several
of these proteins have been introduced into transgenic crops
that have been consumed worldwide and none of them has
been shown to elicit allergic reactions in humans or animals
(Mendelsohn et al., 2003). Sequence analysis of Cry1Ia1
protein revealed no similarity to known allergens and because
the Cry1Ia1 protein digests rapidly and does not show stability
in simulated gastric fluid, it does not present an allergenicity
concern. Furthermore, thermostability studies indicated that the
Cry1Ia1 protein is inactivated by heating to 100 C for 3 to 4
min. With normal cooking methods for potatoes (boiling, deep
frying, and baking), the 100 C temperature is exceeded and the
J. AMER. SOC. HORT. SCI. 135(4):325–332. 2010.

Table 4. Summary of food safety tests conducted on Escherichia coli-produced
Cry1Ia1 protein.
Test
Acute toxicity of E. coli Cry1Ia1
Compositional analysis of ‘SpuntaG2’
Subchronic feeding study using feed containing ‘SpuntaG2’
BLASTPy search for similarity between Cry1Ia1 protein and
human or animal (non-arthropod) toxins
Simple FASTA matching between Cry1Ia1 protein and known
allergens in the AllergenOnline database (University of
Nebraska-Lincoln, 2010)
FASTA 80-amino acid sliding window matching between
Cry1Ia1 protein and known allergens in the AllergenOnline database
Simulated gastric fluid digestion of Cry1Ia1 protein
Heat inactivation of Cry1Ia1 protein

Cry1Ia1 protein or the potato cultivar SpuntaG2 expressing
Results
No toxicity (NOAEL = 2000 mgkg–1 body weight per day)z
‘SpuntaG2’ is compositionally equivalent to ‘Spunta’
No evidence of nutritional deficiency of ‘SpuntaG2’
No similarity with human or animal toxins
No matches greater than 35% over 80 amino acid

No matches greater than 35% over 80 amino acid
Digestion in <0.5 min
Toxic activity inactivated in <3 min

z

NOAEL = no adverse effect level.
BLASTP = Basic Local Alignment Search Tool Protein.

y

time of exposure surpasses 3 to 4 min. Therefore, during typical
preparation of potatoes, the Cry1Ia1 protein is completely
inactivated. From the standpoint of allergenicity, this means that
the protein is degraded and, consequently, any allergy-inducing
epitopes would be destroyed. This is additional evidence that the
Cry1Ia1 protein poses no concern for allergenicity.
The nptII gene was included in the construct to transform
‘SpuntaG2’ for use as a selectable marker to identify transformed plants during tissue culture regeneration. Therefore, the
safety of the NPTII protein must be addressed for ‘SpuntaG2’.
The food and feed safety of the enzyme, NPTII produced by
the nptII gene, has been widely assessed. Lack of toxicity and
allergenicity of NPTII as well as the lack of glycosylation of
this protein in planta has already been demonstrated (Fuchs
et al., 1993a, 1993b). Based on this body of evidence, the NPTII
protein has been deemed safe and the npt II gene has been used
in 70 approved transgenic events that include potato, maize
(Zea mays), sugar beet (Beta vulgaris), canola (Brassica rapa),
papaya (Carica papaya), chicory (Cichorium intybus), cotton
(Gossypium hirsutum), flax/linseed (Linum usitatissimum),
tomato (Solanum lycopersicum), tobacco (Nicotiana tabacum),
and plum (Prunus domestica) (AGBIOS, 2010). Twenty of the
approved events containing the nptII gene are in potato.
Furthermore, the level of NPTII protein in ‘SpuntaG2’ leaves
(as determined by ELISA) is consistent with those in other
transgenic potato lines and the protein is equivalent to NPTII
proteins in crops that have been deregulated.
The nutritional composition of ‘SpuntaG2’ was not significantly different from that of non-transgenic ‘Spunta’. Because
the compositional analysis showed equivalence between
‘SpuntaG2’ and ‘Spunta’, a feeding study would not normally
be required. Furthermore, Codex Alimentarius (2003) cautions
that feeding studies employing whole foods have limited value
in safety assessment and must be conducted such that nutritional imbalances by feeding with abnormally high amounts of
the test food are not caused. None-the-less, a rodent feeding
study was conducted as an additional assurance of nutritional
adequacy and absence of unintended effects. In these experiments, the control and experimental groups had no significant
differences for the parameters tested, which is indicative of
compositional equivalency.
In the third article of our three-article series, additional
experiments were done to determine the efficacy of ‘SpuntaG2’
J. AMER. SOC. HORT. SCI. 135(4):325–332. 2010.

for controlling potato tuber moth infestation in the field and
storage and to compare non-transgenic ‘Spunta’ and ‘SpuntaG2’
for agronomic, quality, and processing traits, as well as yield
(Douches et al., 2010). The results of those experiments showed
that ‘SpuntaG2’ gave complete resistance to potato tuber moth
infestation in the field and in storage and that it did not differ
from non-transgenic ‘Spunta’ with respect to yield, other
important agronomic properties, tuber quality, and processing
traits.
Taken as a whole, the results of this study strongly indicate
that Cry1Ia1 protein, along with the NPTII protein and the plant
expressing them, ‘SpuntaG2’, are not a human health risk.
Therefore, using the ‘SpuntaG2’ potato, a safe alternative to
chemical pesticide use, benefits not only the grower, but the
consumer and the environment as well.
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